Nursing Home Abuse: Johnson & Johson Pharmaceuticals Pays 2.2 Billion Settlement As A Result Of Antipsychotic Drug Promotions

Johnson & Johnson, a pharmaceutical company has paid 2.2 billion dollars to settle claims that it improperly promoted the use of antipsychotics for nursing home residents.  As part of this settlement, Janssen, a J&J subsidiary, plead guilty to a misdemeanor criminal charge that Risperdal, an antipsychotic medication, was pushed by sales representatives for uses not approved by the Food and Drug Administration.  Risperdal is approved to treat schizophrenia and was being pushed by sales representatives as useful to control dementia symptoms.  The civil charges included aggressive inappropriate marketing of Risperdal and another antipsychotic drug, Invega, to long term care residents.

To read more:

If you are looking for a nursing home abuse attorney, Russo & Kieck is a full service law firm in Hackensack, New Jersey.  We represent clients throughout Northern New Jersey in Bergen, Essex, Hudson, Morris, Passaic and Union Counties.


Post a Comment

You must be logged in to post a comment.